Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

Cited by (866)

Items 601–700 of 866

1. Driving Out Chronic Lymphocytic Leukemia With CAR T Cells
   Mohamed A. Kharfan‐Dabaja, Farah Yassine, Martha E. Gadd, Hong Qin · 2021 · Transplantation and Cellular Therapy
2. Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
   Nurulhuda Binte Mustafa, Muhamad Irfan Bin Azaman, Giselle G. K. Ng, Wee Joo Chng · 2022 · Biomolecules
3. CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma
   Lorenzo Cuollo, Samuele Di Cristofano, Annamaria Sandomenico, Emanuela Iaccarino, Angela Oliver, Alessandra Zingoni, Marco Cippitelli, Cinzia Fionda, Sara Petillo, Andrea Kosta et al. · 2024 · iScience
4. Arginine Thiazolidine Carboxylate Stimulates Insulin Secretion through Production of Ca2+-Mobilizing Second Messengers NAADP and cADPR in Pancreatic Islets
   Dae‐Ryoung Park, Asif Iqbal Shawl, taegeun Ha, Kwang-Hyun Park, Seon-Young Kim, Uh‐Hyun Kim · 2015 · PLoS ONE
5. Immune therapy in multiple myeloma.
   Katarina Luptakova, David Avigan · 2015 · PubMed
6. Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma
   Shebli Atrash, Syed Abbas Ali, Saad Z. Usmani · 2020 · Clinical Lymphoma Myeloma & Leukemia
7. The safety of daratumumab for the treatment of multiple myeloma
   María José Cejalvo, Paz Ribas, Javier de la Rubia · 2017 · Expert Opinion on Drug Safety
8. CD38 is a good predictor of anti-PD-1 immunotherapy responsiveness in hepatocellular carcinoma
   Siting Goh, Harry Ho Man Ng, Valerie Chew, Xin Ni Sim, Huihua Li, Sherlly Lim, Jeffrey Chun Tatt Lim, Josh Jie Hua Loh, Khin Sabai, Clara Chong Hui Ong et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
9. Correction: CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia
   Chi‐un Choe, Kerstin Lardong, Mathias Gelderblom, Peter Ludewig, Frank Leypoldt, Friedrich Koch‐Nolte, Christian P Gerloff, Tim Ullrich Magnus · 2011 · PLoS ONE
10. Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma
    Amrita Y. Krishnan, Krina K. Patel, Meera Mohan, Sundar Jagannath, Rubén Niesvizky, Rebecca Wang Silbermann, Ziji Yu, Long Tao, Scott R. P. McDonnell, Deborah T. Berg et al. · 2024 · Blood Neoplasia
11. Herring roe oil in treatment of psoriasis – influence on immune cells and cytokine network
    Aleksandra Petrovic, Ingvild Bueide, Kåre Steinar Tveit, Hogne Hallaråker, Bodil Bjørndal, Tim D. Holmes, Richard Davies, Karl Albert Brokstad, Brith Bergum, Silke Appel · 2023 · Frontiers in Immunology
12. Jujuboside a Improved Energy Metabolism in Senescent H9c2 Cells Injured by Ischemia, Hypoxia, and Reperfusion through the CD38/Silent Mating Type Information Regulation 2 Homolog 3 Signaling Pathway
    Yiran Hu, Huiyan Qu, Jia-Ying Guo, Tao Yang, Hua Zhou · 2023 · World Journal of Traditional Chinese Medicine
13. In vitro B cell experiments explore the role of CD24, CD38, and energy metabolism in ME/CFS
    Christopher W. Armstrong, F. Mensah, Maria José Leandro, Venkat R Reddy, Paul R. Gooley, Saul Berkovitz, Geraldine Cambridge · 2024 · Frontiers in Immunology
14. Oxytocin-induced increases in cytokines and clinical effect on the core social features of autism: Analyses of RCT datasets
    Tomoyasu Wakuda, Seico Benner, Yukari Uemura, Tomoko Nishimura, Masaki Kojima, Miho Kuroda, Kaori Matsumoto, Chieko Kanai, Naoko Inada, Taeko Harada et al. · 2024 · Brain Behavior and Immunity
15. Neuropeptides affecting social behavior in mammals: Oxytocin
    Hong Zhou, Rui Zhu, Yuqing Xia, Xinming Zhang, Zixu Wang, George Huntly Lorimer, Reza Arman Ghiladi, Hasan Bayram, Jun Wang · 2024 · Peptides
16. NAD+ enhancers as therapeutic agents in the cardiorenal axis
    Mariano Marin-Blazquez, Jordi Rovira, María José Ramírez-Bajo, Ruben Zapata Perez, Rubén Rabadán-Ros · 2024 · Cell Communication and Signaling
17. The Signaling Protein CD38 Is Essential for Early Embryonic Development
    Dev Churamani, Timothy J. Geach, Latha Ramakrishnan, Nicole Prideaux, Sandip Patel, Leslie Dale · 2012 · Journal of Biological Chemistry
18. CD32 is enriched on CD4dimCD8bright T cells
    Amber K. Virdi, Jennillee Wallace, Hannah J. Barbian, Maureen H. Richards, Ethan Matthew Ritz, Beverly E. Sha, Lena Al‐Harthi · 2020 · PLoS ONE
19. CD38 Defines a Subset of B Cells in Rainbow Trout Kidney With High IgM Secreting Capacities
    Diana L Martin, Pedro Perdiguero, Esther Morel, Irene Soleto, Juan Germán Herranz-Jusdado, Luis Ramón, Beatriz Abós, Tiehui Wang, Patricia Díaz‐Rosales, Carolina Tafalla · 2021 · Frontiers in Immunology
20. Gene expression in asthmatic airway smooth muscle: a mixed bag
    Christopher D. Pascoe, Nicholas E. Swyngedouw, Chun Yong Seow, Peter D. Paré · 2014 · Canadian Journal of Physiology and Pharmacology
21. Enhanced SARS-CoV-2-Specific CD4+ T Cell Activation and Multifunctionality in Late Convalescent COVID-19 Individuals
    Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, Nandhini Selvaraj, Rachel Mariam Renji, Saravanan Munisankar, Jeromie Wesley Vivian Thangaraj, Muthusamy Santhosh Kumar, C. P. Girish Kumar, Tarun Bhatnagar et al. · 2022 · Viruses
22. Association between bone marrow stromal cell antigen 1 gene polymorphisms and the susceptibility to Parkinson’s disease: a meta-analysis
    Shan Wang, Yufeng Xu, Xiaoyan Ding, Zhi-Rong Liu, Yao Ding, Bo Jin, Shuang Wang, Meiping Ding · 2015 · Neuroscience Letters
23. Enzymatic and microenvironmental regulation in adenosine metabolism-mediated immunosuppression
    Chuang Li, Lifeng Chen, Zhihao Li, Ling Liang, Benyong Lou · 2026 · Frontiers in Immunology
24. Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 Inhibitors
    Andrew J. Stott, Roland W. Bürli, Kevin J. Doyle, Louise Dickson, Richard C. Hewer, Philip Pickford, Maxine J. Roberts, Rosie Waters-Hall, Yiming Wu, Matthias Zebisch et al. · 2026 · ACS Medicinal Chemistry Letters
25. Genetic and epigenetic effects on couple adjustment in context of romantic relationship: A scoping systematic review
    Pouria Khani, Mitra Ansari Dezfouli, Farzad Nasri, Maryam Rahemi, Salma Ahmadloo, Hamed Afkhami, Farzane Saeidi, Sergey Yu Tereshchenko, Mohammad Reza Bigdeli, Mohammad Hossein Modarressi · 2023 · Frontiers in Genetics
26. Meta-analysis of the efficacy and safety of daratumumab in the treatment of multiple myeloma
    Pei Wang, Sheng‐Yu Jin · 2023 · World Journal of Clinical Cases
27. Immunometabolism of Innate Immune Cells in Gastrointestinal Cancer
    Izabela Siemińska, Marzena Lenart · 2025 · Cancers
28. Genetic Variations in Elements of the Oxytocinergic Pathway are Associated with Attention/Hyperactivity Problems and Anxiety Problems in Childhood
    Laísa Camerini, Gabriel Zurchimitten, Bertha Bueno Bock, Janaína Xavier, Clarissa Ribeiro Bastos, Evânia Martins, Ana Paula Ardais, Janaína Vieira dos Santos Motta, Andressa Jacondino Pires, Mariana Bonati de Matos et al. · 2022 · Child Psychiatry & Human Development
29. CD38 deficiency promotes skeletal muscle and brown adipose tissue energy expenditure through activating NAD+-Sirt1-PGC1α signaling pathway
    Qi Ding, Ke Wen, Qian Li, Qi‐Hang Zhao, Jia-Le Zhao, Yun‐Fei Xiao, Xiao‐Hui Guan, Meixiu Jiang, Feng Zhang, Ling-Fang Wang · 2023 · Canadian Journal of Physiology and Pharmacology
30. The NADase CD38 may not dictate NAD levels in brain mitochondria of aged mice but regulates hydrogen peroxide generation
    Juliana Camacho-Pereira, Leonardo Osbourne Lai de Souza, Marina Santos Chichierchio, Camila Rodrigues-Chaves, Luiza de Sousa Lomba, Manoel Fonseca-Oliveira, Daniel Carvalho-Mendonça, Thaia Silva-Rodrigues, Antônio Galina · 2023 · Free Radical Biology and Medicine
31. Overexpression of circulating CD38+ NK cells in colorectal cancer was associated with lymph node metastasis and poor prognosis
    Xueling Wang, Haoran Li, Huixian Chen, Kehua Fang, Xiaotian Chang · 2024 · Frontiers in Oncology
32. Daratumumab – Hope for Myeloma Patients, a Challenge for Clinical Laboratories
    Tomáš Jelı́nek, Martin Kořístka, Zuzana Čermáková, Roman Hájek · 2017 · Klinicka onkologie
33. The prospect of genetically engineering natural killer cells for cancer immunotherapy
    Angie Yu Ching Poon, Ryohichi Sugimura · 2022 · Biology Open
34. A Case of Panagglutination on Antibody Identification in a Multiple Myeloma Patient Receiving Daratumumab
    Jooyoung Cho, Hyunjin Nah, Daewon Kim, Eunkyung Lee, Jin Seok Kim, Hyun Ok Kim · 2016 · The Korean Journal of Blood Transfusion
35. Decreased ADP‐Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy
    Michio Ohtsuji, Kunimasa Yagi, Miyuki Shintaku-Kubota, Yukiko Kojima-Koba, Naoko Ito, Masako Sugihara, Naoto Yamaaki, Daisuke Chujo, Atsushi Nohara, Yoshiyu Takeda et al. · 2008 · Journal of Diabetes Research
36. Amperometric determination of NADH based on a poly-Ni( ii )–curcumin composite film modified glassy carbon electrode
    Xiaoqian Ouyang, Yaping Ding, Xi Ba, Shuqing Gu · 2014 · Analytical Methods
37. Immune surveillance of nasopharyngeal carcinoma (NpC)
    Oluwadayo Oluwadara, André Barkhordarian, Luca Giacomelli, Xenia Brant, Francesco Chiappelli · 2011 · Bioinformation
38. Evaluation of the antiretroviral effects of a PEG-conjugated peptide derived from human CD38
    Thea Bensi, Federico Mele, Massimo Ferretti, Sandro Norelli, Sary El Daker, Annalisa Chiocchetti, José María Rojo, Roberto Cauda, Umberto Dianzani, Andrea Savarino · 2008 · Expert Opinion on Therapeutic Targets
39. Development of chimeric antigen receptors for multiple myeloma
    Carolina Martínez-Cingolani, Jean Christophe Bories · 2016 · Biochemical Society Transactions
40. A Novel PHOX/CD38/MCOLN1/TFEB Axis Important For Macrophage Activation During Bacterial Phagocytosis
    Mehran Najibi, Joseph A. Moreau, Havisha H. Honwad, Javier E. Irazoqui · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
41. All- trans Retinoic Acid Sensitizes Epithelial Ovarian Cancer to PARP Inhibition after Exposure to Cisplatin
    Bingjie Mei, Junyang Li, Dengfeng Wang, Lu Feng, Jianming Huang, Guonan Zhang · 2024 · Molecular Cancer Therapeutics
42. CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma
    Giulia Giorgetti, Elena Maroto-Martín, Debora Soncini, Daniela Fenoglio, Pamela Becherini, Andrea Benzi, Silvia Ravera, Isabella Traverso, Francesco Ladisa, Francesco Lai et al. · 2025 · Blood Cancer Journal
43. Cardiomyocyte specific CD38 deletion protects heart from acute myocardial infarction by activating Sirt3 signaling pathway
    Ke Wen, Yating Zhang, Qi‐Hang Zhao, Qian Li, Jia-Le Zhao, Qi Ding, Yun‐Fei Xiao, Xiao‐Hui Guan, Meixiu Jiang, Yisong Qian et al. · 2025 · Scientific Reports
44. Overcoming therapeutic challenges in acute myeloid leukemia: active targeting strategies by nano-drug delivery systems
    Yu-Qian Tang, Jia-Xing Li, W. Ye, Yiwen Du, Ying Zhang, Yun-Xia Ye, Yu-Ping Gong · 2026 · Journal of Translational Medicine
45. Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective
    Alberto L. Horenstein, Kristine A. Frerichs, Angelo Corso Faini, Niels W.C.J. van de Donk, Fabio Malavasi · 2026 · Frontiers in Immunology
46. NT5E gene and CD38 protein as potential prognostic biomarkers for childhood B-acute lymphoblastic leukemia
    Vitória Brum da Silva Nunes, Camila Kehl Dias, Marco Antônio De Bastiani, Mariela Granero Farias, Fabiane Spagnol, Ana Paula Alegretti, Liane Esteves Daudt, Mariana Bohns Michalowski, Ana Maria Oliveira Battastini, Alessandra Aparecida Paz et al. · 2022 · Purinergic Signalling
47. Characterization of Endo-Lysosomal Cation Channels Using Calcium Imaging
    Christian Wahl‐Schott, Marc Freichel, Konstantin Hennis, Koenraad Philippaert, Roger Ottenheijm, Volodymyr Tsvilovskyy, Hristo Varbanov · 2023 · Handbook of experimental pharmacology
48. Translating mechanisms into therapeutic strategies for immune thrombocytopenia (ITP): Lessons from clinical trials
    Mahda Delshad, Zeinab Davoodi‐Moghaddam, Atieh Pourbagheri‐Sigaroodi, Mohammad Faranoush, Hassan Abolghasemi, Davood Bashash · 2024 · Thrombosis Research
49. Immune Cell Proteins and Parkinson's Disease: A Mendelian Randomization Analysis of Causal Associations
    Haining Li, Jianhang He, Tingting Xuan, Shue Gu, Xiaoyan Niu, Yazhou Ren, Xiuping Zhan, Jiang Cheng · 2025 · Brain and Behavior
50. The oxytocin-CD38-vitamin A axis in pregnant women involves both hypothalamic and placental regulation
    Moriya Gamliel, Karen L. Anderson, Richard P. Ebstein, Nurit Yirmiya, David Mankuta · 2015 · The Journal of Maternal-Fetal & Neonatal Medicine
51. CD38 and Behavior: Moving from Correlation to Causality?
    Enrico Brunetti, Fabio Malavasi · 2012 · Biological Psychiatry
52. Clinical significance of serum ADP-ribosylation and NAD glycohydrolase activity in patients with colorectal cancer
    Başak Varol, Özlem Coşkun, Senem Karabulut, Kursat Rahmi Serin, Oktar Asoğlu, İşıl Albeniz, Faruk Taş, Rüstem Nurten · 2014 · Tumor Biology
53. TNFRSF12A and CD38 Contribute to a Vicious Circle for Chronic Obstructive Pulmonary Disease by Engaging Senescence Pathways
    Yan Dong, Hongbao Cao, Rongyuan Cao, Ancha V. Baranova · 2020 · Frontiers in Cell and Developmental Biology
54. Oxytocin Pathway Gene (CD38, OXTR) Variants Are Not Related to Psychosocial Characteristics Defined by Strengths and Difficulties Questionnaire in Adolescents: A Field School-Based Study
    Sergey Yu Tereshchenko, Э. В. Каспаров, Зобова Светлана Николаевна, M. V. Smolnikova, Lidia Semyonovna Evert, Olga Zaitseva, Ольга Исаевна Зайцева, Gorbacheva Nina, Ludmila Lapteva, Nadezhda Semenova · 2021 · Frontiers in Psychiatry
55. A new era of immuno-oncology in acute myeloid leukemia - antibody-based therapies and immune checkpoint inhibition
    Anita Geevarghese Koshy, Naval Guastad Daver, Amir Tahmasb Fathi · 2020 · Best Practice & Research Clinical Haematology
56. Expression of CD38 in Mast Cells: Cytological and Histotopographic Features
    Dmitri Atiakshin, Vera E. Samoilova, Igor Buchwalow, Markus Tiemann · 2021 · Cells
57. Development of the Fc-III Tagged Protein Expression System for Protein Purification and Detection
    Shan Feng, Enbing Tian, Lei Zhang, Qingtao Wang, Haiteng Deng · 2012 · PLoS ONE
58. Astroglial CD38 impairs hippocampal synaptic plasticity after global cerebral ischemia
    Amelia M. Burch, Ami Haas, James E. Orfila, Erika Tiemeier, Cassidy De Anda Gamboa, Nicholas Chalmers, Nidia Quillinan, Paco S. Herson · 2024 · Frontiers in Stroke
59. The ATP-mediated cytokine release by macrophages is down-modulated by unconventional α9* nicotinic acetylcholine receptors
    Philipp M. K. Wolf, Dominik Hanke, Vijay Kumar Singh, Hanno L. Keller, Luca J. Ettischer, Laura Teppe, Anca‐Laura Amati, Andreas Hecker, Faeq Husain‐Syed, Marius Rohde et al. · 2025 · Frontiers in Immunology
60. Chimeric antigen receptor-based cellular therapy for T-cell malignancies
    Sile Li, Yuan‐Xin Li, Man Yan Hui, Asif Rashid, Hong Kee Tan, Shing Chan, Wilson Yau Ki Chan, Kee See Lam, Wenwei Tu, Wing Hang Leung · 2025 · Critical Reviews in Oncology/Hematology
61. Myeloid‐Derived CD38 Mediates Age‐Related Endometrial Aging Through NAD + Depletion
    Lun Hua, Luting Liu, Dengfeng Gao, Lulu Ma, Xianyang Jin, Liuyong Lu, Shangbo Tian, Xuemei Jiang, Chao Jin, Bin Feng et al. · 2025 · Aging Cell
62. CD38 degrades MAVS through mitophagy to inhibit type I interferon secretion in nasopharyngeal carcinoma cells and impairs CD8+T cell-mediated anti-tumor immunity
    Lin Liang, Wentao Li, Siyi Liu, Qian He, Feng Zeng, Jiaying Cao, Yan Lei, Yanling Li, Yanhong Zhou · 2026 · Nature Communications
63. Evolving understandings for the roles of CD38 protein in autoimmunity and autoimmune disease
    Xiaochun Ye, Jieying Zhang, Mengping Song, Ping Wang, Irma Arés, Bernardo López-Torres, Marta Martínez, María‐Rosa Martínez‐Larrañaga, Jorge-Enrique Maximiliano, Arturo Anadón et al. · 2026 · Clinical & Experimental Immunology
64. Daratumumab – breakthrough drug in multiple myeloma therapy
    Artur J. Jurczyszyn, Agata Kosmaczewska, Aleksander B. Skotnicki · 2014 · Postępy Higieny i Medycyny Doświadczalnej
65. Causality between gut microbiota, immune cells, and breast cancer: Mendelian randomization analysis
    Rui Lv, Danyan Wang, Tengyue Wang, Rongqun Li, Zhuang Aiwen · 2024 · Medicine
66. The Problem of Molecular Target Choice for CAR-T Cells in Acute Myeloid Leukemia Therapy
    Varvara Maiorova, Murad D. Mollaev, П. Н. Вихрева, А. В. Кибардин, Michael A Maschan, Sergey S. Larin · 2025 · International Journal of Molecular Sciences
67. Clinical and pathogenetic peculiarities of development of endothelial dysfunction and arterial rigidity in patients with chronic obstructive pulmonary disease
    Мамаева Марина Геннадьевна, Ирина Владимировна Демко, Alla Borisovna Salmina, Elena A. Sobko, Natalia A. Malinovskaya, А. Yu. Kraposhina, Natalia V. Gordeeva, Irina A. Soloveva · 2016 · Clinical Medicine (Russian Journal)
68. Possible Therapeutic Potential of Flavonoids and Phenolic Acids from Honey in Age-Related Neurodegenerative Diseases Via Targeting NAD+ Degradation
    Andleeb Khan, Saeed Alshahrani, Azher Mustafa Arafah, Wajhul Qamar, Ambreen Shoaib, Adil Farooq Wali, Insha Amin, Saad S. Alqahtani, Muneeb U. Rehman · 2020 · Springer eBooks
69. CD38 Facilitates Recovery from Traumatic Brain Injury
    Ayelet Levy, Adi Bercovich-Kinori, Alexander G. Alexandrovich, Jeanna Tsenter, Victoria Trembovler, Frances E. Lund, Esther Shohami, Reuven Stein, Lior Mayo · 2009 · Journal of Neurotrauma
70. Identification of a small chemical as a lysosomal calcium mobilizer and characterization of its ability to inhibit autophagy and viral infection
    Kehui Zhang, Lihong Huang, Yang Cai, Yi Zhong, Nanjun Chen, Fei Gao, Liang N. Zhang, Qi Li, Zhenming Liu, Rongxin Zhang et al. · 2023 · FEBS Journal
71. Identification of G4 motifs of various stem cell markers and their biophysical and biochemical characterization
    Sarvpreet Kaur, Nikita Kundu, Taniya Sharma, Jadala Shankaraswamy, Sarika Saxena · 2023 · Journal of Biomolecular Structure and Dynamics
72. Chimeric Antigen Receptor T-cell Therapy for Chronic Lymphocytic Leukemia: What is the supporting evidence so far?
    Razan Mohty, Shaykhah Alotaibi, Martha E. Gadd, Yan Luo, Ricardo Daniel Parrondo, Hong Qin, Mohamed A. Kharfan‐Dabaja · 2023 · Clinical Hematology International
73. Cutaneous melanoma and purinergic modulation by phenolic compounds
    Geórgia de Carvalho Braga, João Victor Coiado, Vitória Capelli de Melo, Brenno Bianchoni Loureiro, Margarete Dulce Bagatini · 2024 · Purinergic Signalling
74. Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials
    Francisco Cézar Aquino de Moraes, Vitor Kendi Tsuchiya Sano, Artur de Oliveira Macena Lôbo, Francinny Alves Kelly, Victória Morbach, Eric Pasqualotto, Rommel Mário Rodríguez Burbano · 2024 · Journal of Personalized Medicine
75. Redox state of NAD modulates the activation of Na-bicarbonate cotransporter NBCe1-B via IRBIT and L-IRBIT
    Tianxiang Gui, Ying Liu, Mingfeng Fu, Han Wu, Su Pan, Xuhui Feng, Mengmeng Zheng, Zixuan Huang, Xudong Luo, Walter F. Boron et al. · 2025 · Science China Life Sciences
76. Clinical Investigations. T-Lymphocyte Subset Absolute Counts in the Peripheral Blood of Mediterranean Spotted Fever Patients: Relations to Disease Severity / Абсолютное Количество Субпопуляций Т-Лимфоцитов В Перифери- Ческой Крови Пациентов Со Средиземноморской Пятнистой Лихо- Радкой: Установление Связи С Тяжестью Заболевания
    Ivan Baltadzhiev, Pavel I. Pavlov · 2015 · Folia Medica
77. Association of CD49d expression with clinicopathological features of chronic lymphocytic leukemia patients in the Iranian population.
    Pardis Nematollahi, Mina Shakery, Amirhosein Kefayat, Parvin Goli · 2020 · PubMed Central
78. Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trials
    Jasmeet Kaur, Paramveer Singh, Thomas Enzler, Vaibhav Sahai · 2021 · Expert Opinion on Emerging Drugs
79. Metabolic targets in cardiac aging and rejuvenation
    Chang Liu, Xiao Zhang, Meiyu Hu, Yi Lu, Priyanka Gokulnath, Gururaja Vulugundam, Junjie Xiao · 2022 · The Journal of Cardiovascular Aging
80. Alteration of Neuron-Glia Interactions in Neurodegeneration: Molecular Biomarkers and Therapeutic Strategy
    Bucharskaya Alla, Marina M., E. Tatyana, V Prokopenko Semen, A Sivakova Natalia, Shirokova Olesya, I. Alyona, V Shevelkov Andrei, Alexander A. · 2011 · InTech eBooks
81. Two-Photon Permeabilization and Calcium Measurements in Cellular Organelles
    Oleg V. Gerasimenko, Julia V. Gerasimenko · 2009 · Methods in molecular biology
82. NAD+-Consuming Enzymes in the Regulation of Lung Immune Responses
    Agnieszka Legutko, Pierre M. Lekeux, Fabrice Bureau · 2009 · The Open Immunology Journal
83. Daratumumab therapy for relapsed or refractory multiple myeloma: a single-center retrospective study
    Kazutaka Sunami, Hiroyuki Murakami, Hisashi Tagashira, Hiroko Ueda, Takashi Moriyama, T Ishikawa, Takanori Yoshioka, Masanori Makita · 2020 · International Journal of Clinical Oncology
84. Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder
    Trine Engelbrecht Hybel, Maja Ølholm Vase, Eva Futtrup Maksten, Marie Beck Enemark, Kristina Lystlund Lauridsen, Stephen Jacques Hamilton-Dutoit, Claus B. Andersen, Michael Boe Møller, Søren Schwartz Sørensen, Bente Jespersen et al. · 2021 · Acta Oncologica
85. Nicotinamide Adenine Dinucleotide (NAD)
    Mathias Ziegler · 2012 · Springer eBooks
86. Proportional and functional anomalies of CD38+ NK Cells:A new mechanism for impaired anti-tumour immunity in multiple myeloma?
    Huixian Chen, Kehua Fang, Jinbao Zong, Xiaotian Chang · 2025 · Immunobiology
87. Non-Competitive Binding of Isatuximab and Daratumumab to CD38: Implications for Targeted Therapy in Multiple Myeloma
    Rubén Osuna‐Gómez, Jordi López‐Pardo, Maria Mulet, Josep F. Nomdedeu, Elisabet Cantó, Rosa Ortín, Ángela Sánchez Cayuela, Maria Angels Ortiz, Albert Guinart-Cuadra, Sílvia Vidal · 2025 · Pharmaceutics
88. Long-term high-protein diet intake accelerates adipocyte senescence through macrophage CD38-mediated NAD+ depletion
    Xiaohan Yang, Lun Hua, Dengfeng Gao, Yanni Wu, Yi Yang, Xianyang Jin, Xuemei Jiang, Chao Jin, Bin Feng, Lianqiang Che et al. · 2025 · Molecular Metabolism
89. The role of CD38 in monocytes during fibrotic progression of myeloproliferative neoplasms
    Yiru Yan, Jinqin Liu, Songyang Zhao, Fuhui Li, Lin Yang, Zefeng Xu, Tiejun Qin, Xiaofan Zhu, Wenbin An, Zhongxun Shi et al. · 2025 · Blood
90. Enzymatic and Chemical Synthesis for ADP‐Ribosylation Using NAD + as Building Blocks: New Concerns in Reaction Discovery and Design
    Yiran Liu, Yanbo You, Lingjun Li · 2026 · ChemBioChem
91. Discovery of Potent and Orally Bioavailable Novel Cluster of Differentiation 38 (CD38) Small Molecule Inhibitors
    Reza Shiroodi, Timothy J. Montavon, Brandon M. Nelson, John T. Randolph, Daniel E. O’Flynn, Leo Iu, Charles W. Hutchins, Tomas Baikstis, Javier Izquierdo, Don Smyth et al. · 2026 · Journal of Medicinal Chemistry
92. Evolution in Research of Ryanodine Receptors and Its Subtype 2 Regulators*
    Yu-Ming LI, Guangju Ji · 2011 · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
93. Synthesis and Evaluation of Thiazoloquinolinones with Linkers To Enable Targeting of CD38
    Stephen S. Scully, Zachary Minden, Ratul Mukerji, Elizaveta A. Andrianova, James Kaberna, Scott P. Lentini, Carlos Tassa, Zhaolin Wang, Susan C. Low, Kevin A. McDonnell · 2016 · ACS Medicinal Chemistry Letters
94. Recent Updates on Multiple Myeloma
    Khalid Ahmed Al-Anazi · 2022 · IntechOpen eBooks
95. CD38 gene polymorphisms and genetic susceptibility to chronic lymphocytic leukemia
    Morteza Hashemi, Hadi Esmaeili Gouvarchin Ghaleh, Shahrbano Rostami, Bahman Jalali Kondori · 2022 · Iranian Journal of Blood and Cancer
96. BST-1 aggravates aldosterone-induced cardiac hypertrophy via the Ca2+/CaN/NFATc3 pathway
    Yuan Yao, Lina Zhao, Hongjuan Cao, Sha Li, Chunyan Liao, Lei Fu, Xing Wang, Fuqin Huang, Weidan Zeng, Aiyue Li et al. · 2023 · General Physiology and Biophysics
97. Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19
    Luna Acharya, Alpana Garg, Manoj Rai, Rupesh Kshetri, Udhayvir Singh Grewal, Prajwal Dhakal · 2023 · Journal of Investigative Medicine
98. The role of selected polymorphisms in regulation of gene CD38 expression and their effect on the clinical picture of autism spectrum disorders – preliminary study
    Krzysztof Maria Wilczyński, Aleksandra Auguściak-Duma, Lena Cichoń, Aleksandra Stasik, Małgorzata Honorata Janas-Kozik · 2024 · Psychiatria Polska
99. NAD Pathways in Diabetic Coronary Heart Disease: Unveiling the Key Players
    Yuan Liu, Wenjing Zhan, Lexun Wang, Weixuan Wang · 2024 · Current Medicinal Chemistry
100. Profiling genetically driven alternative splicing across the Indonesian archipelago
     Neke Ibeh, Pradiptajati Kusuma, Chelzie Crenna Darusallam, Safarina G. Malik, Herawati Sudoyo, Davis James McCarthy, Irene Gallego Romero · 2024 · The American Journal of Human Genetics